{"id":"vaginal-estrogen-daily","safety":{"commonSideEffects":[{"rate":"null","effect":"Vaginal discharge"},{"rate":"null","effect":"Vaginal bleeding"},{"rate":"null","effect":"Headache"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Vaginal estrogen therapy works by releasing estrogen directly into the vagina, which helps to restore the natural balance of estrogen in the body. This can help to alleviate symptoms such as vaginal dryness, itching, and burning, as well as hot flashes and night sweats.","oneSentence":"Estrogen replacement therapy to alleviate menopausal symptoms.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:54:29.036Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment of moderate to severe dyspareunia, a symptom of vulvar and vaginal atrophy, due to menopause or breast cancer treatment"}]},"trialDetails":[{"nctId":"NCT06851754","phase":"PHASE3","title":"Hormone Replacement Therapy in Adolescents With Premature Ovarian Insufficiency","status":"RECRUITING","sponsor":"Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)","startDate":"2025-07-17","conditions":"Premature Ovarian Insufficiency","enrollment":185},{"nctId":"NCT05457972","phase":"PHASE4","title":"Postpartum Vaginal Estrogen for Breastfeeding Patients","status":"RECRUITING","sponsor":"University Hospitals Cleveland Medical Center","startDate":"2025-02-22","conditions":"Breastfeeding, Postpartum Sexual Dysfunction, Vaginal Atrophy","enrollment":100},{"nctId":"NCT07425990","phase":"NA","title":"FET-LET-2x2: Clinical Pregnancy Rates After Frozen Embryo Transfer in Natural and Modified Natural Cycles","status":"NOT_YET_RECRUITING","sponsor":"University of Novi Sad","startDate":"2026-02","conditions":"Infertility Female, Frozen Embryo Transfer (FET)","enrollment":120},{"nctId":"NCT07422506","phase":"NA","title":"A Real-World Study Comparing the Efficacy of Different Treatment Regimens for Early Missed Abortion","status":"RECRUITING","sponsor":"The Third Xiangya Hospital of Central South University","startDate":"2024-01-01","conditions":"Missed Abortion, Early Pregnancy Failure","enrollment":580},{"nctId":"NCT05672901","phase":"NA","title":"Silicone Gel vs. Estrogen Vaginal Cream for the Management of Genitourinary Syndrome of Menopause","status":"RECRUITING","sponsor":"Stratpharma AG","startDate":"2023-04-04","conditions":"Genitourinary Syndrome of Menopause","enrollment":100},{"nctId":"NCT06780163","phase":"PHASE4","title":"Effect of Vaginal Estrogen on Alterations in the Urine Microbiome of Menopausal Women With Overactive Bladder","status":"COMPLETED","sponsor":"Mahidol University","startDate":"2025-06-27","conditions":"Overactive Bladder (OAB), Menopause, Microbiome","enrollment":30},{"nctId":"NCT05573334","phase":"NA","title":"Vaginal Care System for Menopausal Women With Urinary Tract Infections","status":"COMPLETED","sponsor":"Vaginal Biome Science","startDate":"2023-07-10","conditions":"Urinary Tract Infections, Vaginal Flora Imbalance","enrollment":8},{"nctId":"NCT06873971","phase":"NA","title":"Er:YAG Laser Combined With Vaginal Estriol for Genitourinary Syndrome of Menopause","status":"RECRUITING","sponsor":"University of Nove de Julho","startDate":"2025-12-10","conditions":"Genitourinary Syndrome of Menopause","enrollment":60},{"nctId":"NCT07260825","phase":"PHASE2, PHASE3","title":"Use of Topical Testosterone and Estrogen vs Estrogen Alone in Vulvodynia: a Randomized Controlled Trial","status":"NOT_YET_RECRUITING","sponsor":"TriHealth Inc.","startDate":"2025-12","conditions":"Vulvodynia, Dyspareunia, Lichen Sclerosus of Vulva","enrollment":44},{"nctId":"NCT07171970","phase":"NA","title":"IVM - Fresh ET (THE SAIGON PROTOCOL) Versus IVF - FET in PCOS Women","status":"RECRUITING","sponsor":"Mỹ Đức Hospital","startDate":"2025-09-22","conditions":"Polycystic Ovary Syndrome (PCOS), In Vitro Maturation of Oocytes, Fresh Embryo Transfer","enrollment":600},{"nctId":"NCT04833140","phase":"PHASE3","title":"Estrogen Administration for the Treatment of NASH in Postmenopausal Women","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2021-12-02","conditions":"NASH - Nonalcoholic Steatohepatitis","enrollment":60},{"nctId":"NCT05562518","phase":"PHASE4","title":"GRACE-trial: a Randomized Active-controlled Trial for vulvovaGinal atRophy in breAst Cancer Patients on Endocrine Therapy.","status":"RECRUITING","sponsor":"University Hospital, Ghent","startDate":"2022-03-21","conditions":"Vulvovaginal Atrophy, Breast Cancer","enrollment":160},{"nctId":"NCT07030426","phase":"PHASE3","title":"Vaginal Estrogen for Improvement of Outcomes Following Pelvic Organ Prolapse Surgery","status":"NOT_YET_RECRUITING","sponsor":"Queen's University","startDate":"2025-10-01","conditions":"Pelvic Organ Prolapse (POP)","enrollment":180},{"nctId":"NCT06197295","phase":"PHASE4","title":"Efficacy of Combined Pharmacotherapy Versus Solifenacin With Vaginal Estrogen Cream for Women With Detrusor Overactivity","status":"RECRUITING","sponsor":"Mackay Memorial Hospital","startDate":"2022-06-16","conditions":"Urinary Bladder, Overactive, Effect of Drug","enrollment":200},{"nctId":"NCT06479720","phase":"PHASE4","title":"Efficacy of Solifenacin or Mirabegron With Local Estrogen Versus Combination Pharmacotherapy for Overactive Bladder","status":"RECRUITING","sponsor":"Mackay Memorial Hospital","startDate":"2022-06-16","conditions":"Effect of Drug, Urinary Bladder, Overactive","enrollment":300},{"nctId":"NCT05483634","phase":"","title":"Compare Vaginal Estrogen and Platelet-rich Plasma Over Women With Genitourinary Syndrome of Menopause","status":"NOT_YET_RECRUITING","sponsor":"Mackay Memorial Hospital","startDate":"2025-12-01","conditions":"Menopause, Platelet-rich Plasma, Estrogen Replacement Therapy","enrollment":40},{"nctId":"NCT02218463","phase":"NA","title":"Treatment of Prepubertal Labial Adhesions","status":"COMPLETED","sponsor":"Children's Mercy Hospital Kansas City","startDate":"2014-09","conditions":"Prepubertal Labial Adhesions","enrollment":43},{"nctId":"NCT06508944","phase":"PHASE4","title":"Efficacy of Vaginal 17β-Estradiol on the Urinary Storage Symptoms in Postmenopausal Women","status":"COMPLETED","sponsor":"Mahidol University","startDate":"2024-04-08","conditions":"Lower Urinary Tract Symptoms, Female Genitourinary Disease, Urinary Stress Incontinence","enrollment":86},{"nctId":"NCT06280560","phase":"","title":"Impact of IVF Hormonal Therapy on Endometrial Receptivity and Endometrial Senescent Cell Pathological Accumulation","status":"RECRUITING","sponsor":"Fundación IVI","startDate":"2024-02-01","conditions":"Endometrial Receptivity","enrollment":60},{"nctId":"NCT05980091","phase":"PHASE1","title":"Optimal Timing of Euploid Day 6 Blastocyst Transfer in Frozen HRT Cycles, Day 6 or Day 7 of Progesterone Administration.","status":"RECRUITING","sponsor":"ART Fertility Clinics LLC","startDate":"2023-09-22","conditions":"Infertility, Fertility Issues, Infertility, Female","enrollment":316},{"nctId":"NCT06074055","phase":"NA","title":"PRogrammed Versus Modified Natural Cycle After Euploid Failed Embryo Transfer","status":"TERMINATED","sponsor":"Reproductive Medicine Associates of New Jersey","startDate":"2023-10-25","conditions":"Infertility, Female","enrollment":9},{"nctId":"NCT03976544","phase":"PHASE4","title":"Natural Cycle Versus Hormone Replacement Therapy Cycle for a Frozen-thawed Embryo Transfer in PGT Patients","status":"TERMINATED","sponsor":"CRG UZ Brussel","startDate":"2019-05-25","conditions":"Miscarriage, Frozen Embryo Transfer, Natural Cycle","enrollment":362},{"nctId":"NCT05283421","phase":"NA","title":"Improving Diagnostics in Cervical Dysplasia","status":"RECRUITING","sponsor":"University of Aarhus","startDate":"2023-08-23","conditions":"Cervical Cancer","enrollment":150},{"nctId":"NCT06654570","phase":"PHASE2","title":"Effects of Vaginal Estrogen on Serum Estradiol During Aromatase Inhibitor Therapy in Breast Cancer Patients with Vulvovaginal Atrophy: a Prospective Trial","status":"COMPLETED","sponsor":"Helsinki University Central Hospital","startDate":"2020-04-08","conditions":"Breast Cancer","enrollment":20},{"nctId":"NCT05221021","phase":"PHASE4","title":"Vaginal Estradiol vs Oral Beta-3 Agonist for Overactive Bladder Syndrome","status":"RECRUITING","sponsor":"Walter Reed National Military Medical Center","startDate":"2022-10-01","conditions":"Overactive Bladder Syndrome","enrollment":152},{"nctId":"NCT06425978","phase":"PHASE4","title":"Efficacy of the Use of Cellular Matrix/ A-CP-HA Kit","status":"RECRUITING","sponsor":"Fundación Santiago Dexeus Font","startDate":"2024-05-30","conditions":"Genitourinary Syndrome of Menopause","enrollment":192},{"nctId":"NCT04092829","phase":"NA","title":"Impact of Corpus Luteum Presence or Absence in the Incidence of Preeclampsia After Frozen Embryo Transfer","status":"TERMINATED","sponsor":"Instituto Valenciano de Infertilidad, IVI VALENCIA","startDate":"2019-09-16","conditions":"Pre-Eclampsia, Frozen Embryo Transfer","enrollment":591},{"nctId":"NCT05189145","phase":"NA","title":"Hormonal Monitoring and Progesterone Adjustment in Frozen Embryo Transfer Cycles","status":"COMPLETED","sponsor":"Alexandria University","startDate":"2019-10-01","conditions":"Female Infertility","enrollment":600},{"nctId":"NCT06144814","phase":"NA","title":"A Comparison of Hyaluronic Acid and Estradiol Treatment in Vulvovaginal Atrophy.","status":"COMPLETED","sponsor":"Koru Health Groups","startDate":"2023-04-05","conditions":"Vulvovaginal Atrophy","enrollment":300},{"nctId":"NCT05528835","phase":"","title":"Caesarean Section and Intracytoplasmic Sperm Injection (ICSI) Outcome","status":"COMPLETED","sponsor":"Alexandria University","startDate":"2022-01-01","conditions":"Female Infertility","enrollment":140},{"nctId":"NCT04487392","phase":"PHASE2","title":"Photobiomodulation Effect on Vulvovaginal Atrophy in Postmenopausal Women.","status":"WITHDRAWN","sponsor":"University of Nove de Julho","startDate":"2020-12-15","conditions":"Vulvovaginal Atrophy","enrollment":""},{"nctId":"NCT05863975","phase":"PHASE4","title":"Treatment of HPV Infection in Perimenopausal and Postmenopausal Women","status":"UNKNOWN","sponsor":"Qianfoshan Hospital","startDate":"2023-07-01","conditions":"HPV Infection","enrollment":150},{"nctId":"NCT03943823","phase":"PHASE4","title":"Postmenopausal Pessary Users: Estrogen Versus Trimosan","status":"TERMINATED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2019-05-07","conditions":"Vaginosis, Vaginosis, Bacterial, Vaginal Discharge","enrollment":4},{"nctId":"NCT03803228","phase":"PHASE3","title":"Dual Ovarian Stimulation (DUOSTIM) for Poor Ovarian Responders","status":"COMPLETED","sponsor":"Centre Hospitalier Intercommunal Creteil","startDate":"2018-09-03","conditions":"Fertility Disorders","enrollment":88},{"nctId":"NCT04606550","phase":"NA","title":"MonaLisa Laser Intervention for Post-Menopausal Breast Cancer Patients: A SHE CAN Study","status":"WITHDRAWN","sponsor":"Mount Sinai Hospital, Canada","startDate":"2021-09-01","conditions":"Breast Cancer Female, Genitourinary Syndrome of Menopause","enrollment":""},{"nctId":"NCT05340010","phase":"PHASE4","title":"Administration of Human Chorionic Gonadotrophin Before Secretory Transformation of Frozen-thawed Embryo Transfer Cycles","status":"COMPLETED","sponsor":"Alexandria University","startDate":"2020-01-01","conditions":"hCG, FET, Frozen-thawed Embryo Transfe","enrollment":180},{"nctId":"NCT03996057","phase":"PHASE4","title":"Methenamine in a Non-antibiotic, Multimodal Approach to UTI Prevention","status":"WITHDRAWN","sponsor":"Washington University School of Medicine","startDate":"2018-06-20","conditions":"UTI, Female Urogenital Diseases, UTI - Lower Urinary Tract Infection","enrollment":""},{"nctId":"NCT01816139","phase":"PHASE3","title":"Multicenter Study to Evaluate Safety and Efficacy of WC3011 (Estradiol Vaginal Cream) in Postmenopausal Women","status":"COMPLETED","sponsor":"Warner Chilcott","startDate":"2013-01-31","conditions":"Vulvovaginal Atrophy","enrollment":576},{"nctId":"NCT02887885","phase":"","title":"Sustainability of Vaginal Estrogen Therapy in Postmenopausal Women","status":"COMPLETED","sponsor":"Insel Gruppe AG, University Hospital Bern","startDate":"2018-01-22","conditions":"Atrophy of Vagina, Postmenopause","enrollment":32},{"nctId":"NCT03395288","phase":"PHASE2, PHASE3","title":"Nutraceutical Efficacy for rUTI","status":"TERMINATED","sponsor":"Washington University School of Medicine","startDate":"2018-03-22","conditions":"Urinary Tract Infections","enrollment":61},{"nctId":"NCT03837015","phase":"PHASE1","title":"Estrogen, Probiotics and Vaginal Health to Prevent HIV Infection in ACB Women","status":"COMPLETED","sponsor":"McMaster University","startDate":"2019-11-04","conditions":"HIV-1-infection, Bacterial Vaginoses","enrollment":50},{"nctId":"NCT00563576","phase":"NA","title":"Pilot Study of Femring Estrogen Supplementation During Depo-Provera Initiation","status":"COMPLETED","sponsor":"Columbia University","startDate":"2007-09","conditions":"Metrorrhagia","enrollment":71},{"nctId":"NCT01738152","phase":"NA","title":"Non-Hormonal Vaginal Moisturizer in Hormone-Receptor Positive Postmenopausal Cancer Survivors Experiencing Estrogen Deprivation Symptoms on Vulvovaginal Health","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2012-11","conditions":"Breast Cancer, Endometrial Cancer","enrollment":106},{"nctId":"NCT04797338","phase":"PHASE4","title":"Gonadotropin Releasing Hormone Agonist (GnRHa) Versus Estrogen and Progesterone for Luteal Support in High Responders","status":"UNKNOWN","sponsor":"Assaf-Harofeh Medical Center","startDate":"2017-12-29","conditions":"Pregnancy Early, Miscarriage, Ovarian Hyperstimulation Syndrome","enrollment":100},{"nctId":"NCT03779633","phase":"PHASE4","title":"Preoperative Oestrogen in Postmenopausal Women With Pelvic Organ Prolapse","status":"COMPLETED","sponsor":"Medical University of Vienna","startDate":"2017-02-02","conditions":"Pelvic Organ Prolapse","enrollment":120},{"nctId":"NCT02691936","phase":"NA","title":"Comparison of Vaginal Laser Therapy to Vaginal Estrogen Therapy","status":"COMPLETED","sponsor":"The Cleveland Clinic","startDate":"2016-03","conditions":"Atrophic Vaginitis, Menopause","enrollment":69},{"nctId":"NCT04013438","phase":"PHASE3","title":"Luteal Phase Support During Frozen Embryo Transfer Cycle","status":"COMPLETED","sponsor":"Royan Institute","startDate":"2017-11-01","conditions":"Infertility, Female, Frozen Embryo Transfer","enrollment":60},{"nctId":"NCT03032848","phase":"PHASE4","title":"Vaginal Estrogens Comparative Trial on Pelvic Organ Prolapse Patients","status":"COMPLETED","sponsor":"Universidade Federal do Paraná","startDate":"2013-11-26","conditions":"Vaginitis Atropic, Pelvic Organ Prolapse, Endometrial Hyperplasia","enrollment":69},{"nctId":"NCT03832894","phase":"PHASE3","title":"Oestradiol Supplementation in Luteal Long Agonist Fresh In Vitro Fertilization/Intra Cytoplasmic Sperm Injection ( IVF/ICSI) Cycle .","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2018-12-01","conditions":"Infertility","enrollment":2},{"nctId":"NCT03518528","phase":"","title":"Comparison of Vaginal and Transdermal Oestrogen Before Frozen Thawed Embryo Transfer","status":"UNKNOWN","sponsor":"University Hospital, Angers","startDate":"2018-08-30","conditions":"Embryo Transfer, Infertility","enrollment":100},{"nctId":"NCT03540979","phase":"NA","title":"Endometrial Preparation in Frozen Embryo Transfer Cycles","status":"UNKNOWN","sponsor":"Meir Medical Center","startDate":"2018-06","conditions":"Reproductive Behavior","enrollment":100},{"nctId":"NCT03018106","phase":"PHASE4","title":"Ospemifene vs. Conjugated Estrogens in the Treatment of Postmenopausal Sexual Dysfunction","status":"TERMINATED","sponsor":"Emory University","startDate":"2017-06-30","conditions":"Sexual Dysfunction, Physiological","enrollment":1},{"nctId":"NCT00816556","phase":"PHASE3","title":"A Trial to Evaluate the Efficacy of Low Dose Vaginal Estrogens in the Treatment of Atrophic Vaginitis","status":"TERMINATED","sponsor":"Maire Mac Bride","startDate":"2008-10","conditions":"Atrophic Vaginitis","enrollment":63},{"nctId":"NCT01613170","phase":"PHASE4","title":"Premarin Versus Toviaz for Treatment of Overactive Bladder","status":"UNKNOWN","sponsor":"The Cleveland Clinic","startDate":"2012-04","conditions":"Overactive Bladder","enrollment":90},{"nctId":"NCT03120715","phase":"PHASE4","title":"Pregnancy Outcome of Women Using Low Molecular Weight Heparin Before Frozen-thawed Embryo Transfer","status":"UNKNOWN","sponsor":"Nanfang Hospital, Southern Medical University","startDate":"2016-07-01","conditions":"Infertility","enrollment":342},{"nctId":"NCT01546454","phase":"NA","title":"Relationship Between the Menstrual Cycle and Heart Disease in Women","status":"COMPLETED","sponsor":"Oregon Health and Science University","startDate":"2012-02","conditions":"Coronary Heart Disease","enrollment":5},{"nctId":"NCT02419729","phase":"PHASE3","title":"Evaluation of Fractional CO2 Laser Treatment Efficacy and Comparison to Vaginal Estrogen Therapy in Postmenopausal Women With Vulvovaginal Atrophy","status":"COMPLETED","sponsor":"Faculdade de Medicina do ABC","startDate":"2015-03","conditions":"Vulvovaginal Atrophy","enrollment":45},{"nctId":"NCT01813162","phase":"PHASE1","title":"In Vivo Drug Interaction Pharmacokinetic Study of Tenofovir 1% Gel and Three Commonly Used Vaginal Products","status":"COMPLETED","sponsor":"CONRAD","startDate":"2013-12","conditions":"HIV Prevention","enrollment":101},{"nctId":"NCT00361569","phase":"PHASE3","title":"A Clinical Trial to Evaluate the Safety and Efficacy of DR-2041(Synthetic Conjugated Estrogens, A) for Treatment of Vulvovaginal Atrophy","status":"COMPLETED","sponsor":"Duramed Research","startDate":"2006-08","conditions":"Menopause","enrollment":622},{"nctId":"NCT00522873","phase":"PHASE3","title":"Endometrial Safety Study","status":"COMPLETED","sponsor":"Bayer","startDate":"2007-08","conditions":"Postmenopause","enrollment":662},{"nctId":"NCT01778985","phase":"PHASE4","title":"Effect of Preoperative Estrogen Treatment on Connective Tissues of the Pelvic Floor","status":"COMPLETED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2012-12","conditions":"Pelvic Organ Prolapse, Menopause","enrollment":30},{"nctId":"NCT01432028","phase":"NA","title":"Pharmacogenetic Study of Different Hormone Therapies in Recent Menopause Women","status":"COMPLETED","sponsor":"Denusa Wiltgen","startDate":"2007-03","conditions":"Postmenopause","enrollment":90},{"nctId":"NCT00185458","phase":"PHASE3","title":"Assessment of the Transfer of Using Levonorgestrel Intrauterine System (LNG IUS) as a Contraceptive to Using it as Part of Hormone Replacement Therapy (HRT).","status":"COMPLETED","sponsor":"Bayer","startDate":"2000-05","conditions":"Menopause","enrollment":394},{"nctId":"NCT00196378","phase":"PHASE3","title":"A Clinical Trial to Evaluate the Safety and Efficacy of Enjuvia 0.3 mg for the Treatment of Vulvovaginal Atrophy","status":"COMPLETED","sponsor":"Duramed Research","startDate":"2004-11","conditions":"Menopause","enrollment":300},{"nctId":"NCT01367912","phase":"NA","title":"Timing of Estrogen Support During the Luteal Phase of in Vitro Fertilization (IVF)/Intracytoplasmic Sperm Injection (ICSI) Cycle","status":"COMPLETED","sponsor":"Zekai Tahir Burak Women's Health Research and Education Hospital","startDate":"2008-02","conditions":"Infertility","enrollment":301},{"nctId":"NCT00919919","phase":"PHASE2","title":"Efficacy and Tolerability Study of Progesterone Vaginal Tablets (Endometrin®) in Menopausal Women Treated by Estrogen","status":"UNKNOWN","sponsor":"Rabin Medical Center","startDate":"2009-06","conditions":"Endometrial Hyperplasia, Endometrial Cancer","enrollment":60},{"nctId":"NCT00668538","phase":"NA","title":"Uptake of the Antifungal Miconazole and Effect on Estrogen Metabolizing Enzymes in Humans","status":"COMPLETED","sponsor":"University of Southern Denmark","startDate":"2008-04","conditions":"Healthy","enrollment":20}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Conjugated Estrogens CSD, 0.625 mg/g, Vaginal Cream"],"phase":"phase_3","status":"active","brandName":"Vaginal Estrogen - Daily","genericName":"Vaginal Estrogen - Daily","companyName":"Queen's University","companyId":"queen-s-university","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Estrogen replacement therapy to alleviate menopausal symptoms. Used for Treatment of moderate to severe dyspareunia, a symptom of vulvar and vaginal atrophy, due to menopause or breast cancer treatment.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}